| Period Ending | Jan 30, 2013 | Oct 30, 2012 | Jul 30, 2012 | Apr 29, 2012 |
|---|
|
Total Revenue
|
834,681
|
788,398
|
731,649
|
695,467
| | Cost of Revenue | 183,362 | 186,248 | 162,418 | 151,551 | | |
Gross Profit
|
651,319
|
602,150
|
569,231
|
543,916
| |
|
Operating Expenses |
|
Research Development | 121,187 | 114,074 | 99,442 | 94,776 |
|
Selling General and Administrative | 550,939 | 542,264 | 483,255 | 471,389 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(20,807)
|
(54,188)
|
(13,466)
|
(22,249)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 3,119 | (473) | 7,467 | 3,751 |
|
Earnings Before Interest And Taxes | (17,688) | (54,661) | (5,999) | (18,498) |
|
Interest Expense | 8,355 | 8,190 | 8,033 | 6,370 |
|
Income Before Tax | (26,043) | (62,851) | (14,032) | (24,868) |
|
Income Tax Expense | (5,199) | 157,446 | (4,203) | (5,393) |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (20,844) | (220,297) | (9,829) | (19,475) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(20,844)
|
(220,297)
|
(9,829)
|
(19,475)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(20,844)
|
(220,297)
|
(9,829)
|
(19,475)
|
|
0.32(0.68%) 3:01PM EDT - Nasdaq Real Time Price